CEFPODOXIME CLAVULANIC ACID

Background and Date of Approval

Cefpodoxime and Clavulanic Acid form a combination antibiotic for treating a range of bacterial infections. Cefpodoxime is a third-generation cephalosporin that acts bactericidally, whilst Clavulanic Acid is a beta-lactamase inhibitor that prevents certain bacteria from developing resistance to the antibiotic. Together, they provide enhanced and broader activity against infections that may show poor response to antibiotics used singly. Cefpodoxime received FDA approval in 1992, with Clavulanic Acid subsequently incorporated into combination therapy to improve effectiveness. Clinical trials have demonstrated this combination's efficacy against common respiratory tract, urinary tract, and skin infections. The combination is particularly useful in cases where bacterial resistance is suspected or established.

Uses

This combination is prescribed to treat a variety of infections caused by bacteria. It is not effective against viral infections such as the flu or common cold. FDA-approved uses include: Community-acquired pneumonia Acute exacerbation of chronic bronchitis Tonsillitis and pharyngitis Sinusitis Skin and soft tissue infections Urinary tract infections (including cystitis) Gonorrhea (uncomplicated) Acute otitis media (middle ear infection)

Side Effects

While this medicine is generally safe, like any medication, it may cause side effects. These can vary from person to person. Common side effects include: Diarrhea Nausea Stomach pain Headache Vomiting Skin rash Serious side effects (seek medical help immediately): Severe allergic reactions (swelling of face, lips, tongue, or throat) Persistent diarrhea with blood or mucus Yellowing of skin or eyes (signs of liver trouble) Irregular heartbeat or chest discomfort Unusual tiredness or weakness

Warnings

Avoid use if allergic to cephalosporins, penicillins, or beta-lactam antibiotics May interact with certain medications like probenecid, anticoagulants, and diuretics Use with caution in people with a history of kidney disease or gastrointestinal disorders Should not be used without medical advice in pregnant or breastfeeding women May alter results of certain lab tests (e.g., glucose in urine)

Precautions

Before starting the medication, inform your doctor if you have any allergies, kidney problems, or history of intestinal diseases like colitis. People with liver issues or those taking multiple medications should be monitored closely. Children and elderly patients may require dose adjustments based on their condition. Always follow the exact dosage and timing as advised by your healthcare provider to avoid resistance or relapse.

References

https://www.mayoclinic.org/drugs-supplements/cefpodoxime-oral-route/description/drg-20073381 https://go.drugbank.com/drugs/DB01416 https://go.drugbank.com/drugs/DB00766 https://www.ncbi.nlm.nih.gov/books/NBK545273/

Frequently Asked Questions

What is Cefpodoxime, Clavulanic Acid used for?

It is used to treat various bacterial infections such as pneumonia, sinus infections, UTIs, throat infections, and skin infections. It works effectively where regular antibiotics may not be enough, especially in resistant bacterial strains.

 Is Cefpodoxime, Clavulanic Acid safe for children?

Yes, it is commonly prescribed in pediatric doses. However, the dosage depends on the child’s weight and type of infection. Always use the syrup form as advised by a pediatrician.

What is the best time to take this medicine?

It is best taken after meals to improve absorption and reduce the chance of stomach upset. Try to take it at the same times each day to maintain consistent levels in the body.

Can I stop taking the medicine once I feel better?

No, you should complete the full course even if your symptoms improve. Stopping early may cause the infection to come back or lead to antibiotic resistance.

Should this medicine be taken before or after food?

It should be taken after food, as this helps the body absorb the medicine better and reduces the chances of digestive discomfort.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS